Literature DB >> 8905316

Capnocytophaga canimorsus infections in human: review of the literature and cases report.

C Lion1, F Escande, J C Burdin.   

Abstract

Capnocytophaga canimorsus, formerly designated Dysgonic fermenter 2 (DF-2) was first described in 1976; it is a commensal bacterium of dogs and cats saliva, which can be transmitted to man by bite (54% of cases), scratch (8.5%), or mere exposure to animals (27%). We present a review of the clinical and microbiological characteristics of the Capnocytophaga canimorsus infections and 12 cases of infection in France. Over 100 cases of human infections have been reported, mainly septicemia in patients with diminished defences, due to splenectomy (33%), alcohol abuse (24%), immunosuppression (5%). However 40% of septicemia occur in patients with no predisposing conditions. Other infections are less frequent: meningitis, endocarditis, arthritis, pleural and localized eye infections. These infections range from mild to fulminating disease, with shock, respiratory distress, disseminated intravascular coagulation. Dermatological lesions (macular or maculopapular rash, purpura) or gangrene are common. This fastidious Gram-negative bacterium grows slowly on chocolate agar or on heart infusion agar with 5% rabbit blood incubated in 5% CO2. In spite of a great susceptibility of bacteria to antibiotics, the mortality is of 30%. Because of the severity of these infections, taking into account this organism in the management of bites is necessary, especially in patients with predisposing factors.

Entities:  

Mesh:

Year:  1996        PMID: 8905316     DOI: 10.1007/bf00144007

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  71 in total

1.  Dog-bite induced Capnocytophaga canimorsus septicaemia.

Authors:  K Clarke; D Devonshire; A Veitch; R Bellomo; G Parkin
Journal:  Aust N Z J Med       Date:  1992-02

2.  Capnocytophaga canimorsus as the cause of a chronic corneal infection.

Authors:  M D de Smet; C C Chan; R B Nussenblatt; A G Palestine
Journal:  Am J Ophthalmol       Date:  1990-02-15       Impact factor: 5.258

3.  Dysgonic fermenter-2 meningitis simulating viral meningitis.

Authors:  J G Imanse; M C Ansink-Schipper; J A Vanneste
Journal:  Lancet       Date:  1989-08-12       Impact factor: 79.321

4.  Susceptibility of dysgonic fermenter 2 to antimicrobial agents in vitro.

Authors:  A Verghese; F Hamati; S Berk; B Franzus; S Berk; J K Smith
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

Review 5.  [DF-2, a "new" gram-negative bacterium].

Authors:  R Malinverni
Journal:  Schweiz Med Wochenschr       Date:  1990-05-19

6.  Susceptibility testing of Danish isolates of Capnocytophaga and CDC group DF-2 bacteria.

Authors:  A Bremmelgaard; C Pers; J E Kristiansen; B Korner; O Heltberg; W Frederiksen
Journal:  APMIS       Date:  1989-01       Impact factor: 3.205

7.  Dysgonic fermenter organisms and post-splenectomy risks.

Authors:  K G Kerr
Journal:  Lancet       Date:  1987-12-19       Impact factor: 79.321

8.  Musculocutaneous mononeuropathy complicating Capnocytophaga canimorsus infection.

Authors:  T K Banerjee; W Grubb; C Otero; M McKee; R O Brady; N W Barton
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

9.  Capnocytophaga canimorsus bacteraemia demonstrated by a positive blood smear. A case report.

Authors:  G Pedersen; H C Schønheyder; L C Nielsen
Journal:  APMIS       Date:  1993-07       Impact factor: 3.205

10.  DF2 septicaemia.

Authors:  R J Evans
Journal:  J R Soc Med       Date:  1991-12       Impact factor: 18.000

View more
  61 in total

1.  New iron acquisition system in Bacteroidetes.

Authors:  Pablo Manfredi; Frédéric Lauber; Francesco Renzi; Katrin Hack; Estelle Hess; Guy R Cornelis
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  Fibrinolytic therapy in Capnocytophaga canimorsus sepsis after dog bite.

Authors:  A R T van de Ven; A C M van Vliet; B Maraha; H H Ponssen
Journal:  Intensive Care Med       Date:  2004-07-01       Impact factor: 17.440

3.  The dangers of dog bites.

Authors:  David W Wareham; Joy S Michael; Simon Warwick; Paul Whitlock; Alan Wood; Satya S Das
Journal:  J Clin Pathol       Date:  2006-08-30       Impact factor: 3.411

4.  Etiologic diagnosis of Capnocytophaga canimorsus meningitis by broad-range PCR.

Authors:  J Gottwein; R Zbinden; R C Maibach; T Herren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-02       Impact factor: 3.267

5.  Preventing and treating infections in children with asplenia or hyposplenia.

Authors:  Marina I Salvadori; Victoria E Price
Journal:  Paediatr Child Health       Date:  2014-05       Impact factor: 2.253

6.  Answer to May 2017 Photo Quiz.

Authors:  Rongpong Plongla; Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2017-05       Impact factor: 5.948

7.  Persistence of endothelial thrombomodulin in a patient with infectious purpura fulminans treated with protein C concentrate.

Authors:  Pavan K Bendapudi; Alissa Robbins; Nicole LeBoeuf; Olga Pozdnyakova; Ami Bhatt; Fujiko Duke; Ryan Sells; John McQuiston; Ben Humrighouse; Betty Rouaisnel; Meaghan Colling; Kathryn E Stephenson; Arturo Saavedra; Julie-Aurore Losman
Journal:  Blood Adv       Date:  2018-11-13

8.  A small 'lick' will sink a great ship: fulminant septicaemia after dog saliva wound treatment in an asplenic patient.

Authors:  Evi M Morandi; Reinhard Pauzenberger; Christoph Tasch; Ulrich M Rieger; Gerhard Pierer; Gabriel Djedovic
Journal:  Int Wound J       Date:  2017-04-19       Impact factor: 3.315

Review 9.  Capnocytophaga canimorsus: an emerging cause of sepsis, meningitis, and post-splenectomy infection after dog bites.

Authors:  T Butler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-01       Impact factor: 3.267

10.  A patient with bacteraemia and possible endocarditis caused by a recently-discovered genomospecies of Capnocytophaga: Capnocytophaga genomospecies AHN8471: a case report.

Authors:  Jonathan M Mills; Emma Lofthouse; Phil Roberts; Johannis A Karas
Journal:  J Med Case Rep       Date:  2008-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.